⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Mark WuMD

Neurology · Baltimore, MD 21287

NPI: 1619996097

Share:𝕏fin

38

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

309

Total Claims

$11K

Drug Cost

30

Beneficiaries

$380

Cost/Patient

Risk Score Breakdown 38/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+3117%

Opioid rate vs peers

42.1% vs 1.3% avg

-91%

Cost per patient vs peers

$380 vs $4,034 avg

-45%

Brand preference vs peers

5.2% vs 9.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

42.1%

Opioid Rate

130

Opioid Claims

$2,082

Opioid Cost

36.9%

Long-Acting Rate

This provider's opioid prescribing rate of 42.1% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

95% generic

Brand: 16 claims · $4,353

Generic: 293 claims · $7,052

Patient Profile

70

Avg Age

Female

1.10

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About